cell permeable smac-n7-ant peptide (SMAC Corp)
Structured Review
Cell Permeable Smac N7 Ant Peptide, supplied by SMAC Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell-permeable+smac+peptides/smac+peptide/pmc03899364-131-19-21
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Molecular targeting of E3 ligases--a therapeutic approach for cancer. Article Snippet: Background : The ubiquitin-proteasomal degradation pathway plays a critical role in protein degradation and regulates a wide variety of cellular functions.. This highly conserved post-translational modification of proteolytic processes is mainly carried out by substrate-specific E3 ligases.. The deregulation of E3 ligases contributes to cancer development and their overexpression is often associated with poor prognosis. Control:Article Title: Conformationally constrained Smac mimetics and the uses thereof Article Snippet: PC-3 cells were treated with CDDP, Smac peptides and mimetics alone or in combination for 42 hours and apoptosis was analyzed by Annexin V-FITC staining. .. Consistent with previous studies using cell-permeable Article Title: Conformationally constrained Smac mimetics and the uses thereof Article Snippet: PC-3 cells were treated with CDDP, Smac peptides and mimetics alone or in combination for 42 hours and apoptosis was analyzed by Annexin V-FITC staining. .. Consistent with previous studies using cell-permeable Derivative Assay:Article Title: Promoting apoptosis as a strategy for cancer drug discovery. Article Snippet: | Apoptosis is deregulated in many cancers, making it difficult to kill tumours.. Drugs that restore the normal apoptotic pathways have the potential for effectively treating cancers that depend on aberrations of the apoptotic pathway to stay alive.. Apoptosis targets that are currently being explored for cancer drug discovery include the tumournecrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors, the BCL2 family of anti-apoptotic proteins, inhibitor of apoptosis (IAP) proteins and MDM2. |
